Neximmune Inc
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable modality platform. The company's product candidates incl… Read more
Neximmune Inc (NEXI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -2.251x
Based on the latest financial reports, Neximmune Inc (NEXI) has a cash flow conversion efficiency ratio of -2.251x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.07 Million) by net assets ($920.54K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Neximmune Inc - Cash Flow Conversion Efficiency Trend (2018–2023)
This chart illustrates how Neximmune Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Neximmune Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neximmune Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Powerstorm Holdings Inc
PINK:PSTO
|
0.008x |
|
HVA Foods PLC
CM:HVAN0000
|
N/A |
|
CLANCY EXP
BE:CK1
|
N/A |
|
KLEPPER FALTBOOT
BE:KFW1
|
N/A |
|
Filinvest Land Inc
PSE:FLI
|
0.048x |
|
United Arab Shipping
EGX:UASG
|
N/A |
|
Amatheon Agri Holding NV
PA:MLAAH
|
-0.204x |
|
Global-Estate Resorts Inc
PSE:GERI
|
-0.031x |
Annual Cash Flow Conversion Efficiency for Neximmune Inc (2018–2023)
The table below shows the annual cash flow conversion efficiency of Neximmune Inc from 2018 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $3.51 Million | $-31.43 Million | -8.955x | -465.06% |
| 2022-12-31 | $32.30 Million | $-51.19 Million | -1.585x | -189.93% |
| 2021-12-31 | $83.76 Million | $-45.79 Million | -0.547x | -132.61% |
| 2020-12-31 | $-15.75 Million | $-26.40 Million | 1.676x | +191.60% |
| 2019-12-31 | $10.61 Million | $-19.42 Million | -1.830x | -77.90% |
| 2018-12-31 | $10.81 Million | $-11.12 Million | -1.029x | -- |